Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy

SIMPLE SUMMARY: Immuno-oncology has redefined the treatment of lung cancer, with the ultimate goal being the reactivation of the anti-tumor immune response. This has led to the development of several therapeutic strategies focused in this direction. However, a high percentage of lung cancer patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyero, Laura, Sánchez-Gastaldo, Amparo, Alonso, Miriam, Noguera-Uclés, José Francisco, Molina-Pinelo, Sonia, Bernabé-Caro, Reyes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763130/
https://www.ncbi.nlm.nih.gov/pubmed/33322522
http://dx.doi.org/10.3390/cancers12123729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763130/
https://www.ncbi.nlm.nih.gov/pubmed/33322522
http://dx.doi.org/10.3390/cancers12123729

Ejemplares similares